These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1441229)

  • 1. Purification and characterization of porcine C3. Studies of the biologically active protein and its split products.
    Storm KE; Arturson G; Nilsson UR
    Vet Immunol Immunopathol; 1992 Oct; 34(1-2):47-61. PubMed ID: 1441229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of the third component of canine complement.
    Johnson JP; Hammer CH; Winkelstein JA
    Vet Immunol Immunopathol; 1985 Apr; 8(4):377-89. PubMed ID: 4002610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of bovine complement component C3 and its cleavage products.
    Di Carlo AL; Paape MJ; Hellman J; Lilius EM
    Am J Vet Res; 1997 Jun; 58(6):585-9. PubMed ID: 9185962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of tryptic fragments of human complement factor C3.
    Eggertsen G; Hellman U; Lundwall A; Folkersen J; Sjöquist J
    Mol Immunol; 1985 Aug; 22(8):833-41. PubMed ID: 3930949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of the third component of bovine complement.
    Menger M; Aston WP
    Vet Immunol Immunopathol; 1985 Dec; 10(4):317-31. PubMed ID: 3832572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of the porcine complement activation fragments C3c and C3d and their use in the preparation of monospecific antibodies.
    Storm KE; Nilsson UR
    Vet Immunol Immunopathol; 1993 Aug; 37(3-4):231-41. PubMed ID: 8236800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of human complement factors C3, C5 and H.
    Lundwall A; Eggertsen G
    J Immunol Methods; 1985 Jul; 81(1):147-60. PubMed ID: 3160789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and partial characterization of the third component of the complement system from porcine serum (C3) and of a crystallizable degradation product of the fourth component of the complement system from human serum (C4). Study of the tryptic digestion products of human and porcine C3 and of human C4.
    Pâques EP
    Hoppe Seylers Z Physiol Chem; 1980; 361(3):445-56. PubMed ID: 6769776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localisation of a group of antigenic sites in complement component C3, and identification of a new fragmentation pattern.
    Fontaine M; Sim RB
    Biochim Biophys Acta; 1984 Sep; 789(2):119-27. PubMed ID: 6206896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third component of human complement: purification from plasma and physicochemical characterization.
    Tack BD; Prahl JW
    Biochemistry; 1976 Oct; 15(20):4513-21. PubMed ID: 823964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of human and mouse complement C3.
    Ruseva MM; Heurich M
    Methods Mol Biol; 2014; 1100():75-91. PubMed ID: 24218251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large scale isolation of functionally active components of the human complement system.
    Hammer CH; Wirtz GH; Renfer L; Gresham HD; Tack BF
    J Biol Chem; 1981 Apr; 256(8):3995-4006. PubMed ID: 6783652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of the C3 complement component and its C3d subunit from IY-1 fraction of Cohn's fractionation of human plasma.
    Matveevskaya NS; Alyoshkin VA; Rozina MN
    J Chromatogr B Biomed Appl; 1995 Feb; 664(1):261-6. PubMed ID: 7757234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
    Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
    Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of equine complement factor C3.
    Boschwitz JS; Timoney JF
    Vet Immunol Immunopathol; 1993 Sep; 38(1-2):139-53. PubMed ID: 8256433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepitope of human C3 expressed on C3b, iC3b, and C3c.
    Garred P; Mollnes TE; Lea T; Fischer E
    Scand J Immunol; 1988 Mar; 27(3):319-27. PubMed ID: 2451273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of a single chain precursor C3-protein (pro-C3) from normal human plasma.
    Minta JO; Ngan BY; Pang AS
    J Immunol; 1979 Nov; 123(5):2415-20. PubMed ID: 114589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid isolation and characterization of native mouse complement components C3 and C5.
    Van den Berg CW; Van Dijk H; Capel PJ
    J Immunol Methods; 1989 Aug; 122(1):73-8. PubMed ID: 2760478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid FPLC method for purification of the third component of human and guinea pig complement.
    Basta M; Hammer CH
    J Immunol Methods; 1991 Aug; 142(1):39-44. PubMed ID: 1919020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation of C3 cleavage in the alternative complement pathway.
    Fearon DT; Austen KF
    J Immunol; 1975 Nov; 115(5):1357-61. PubMed ID: 809512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.